Commission Regulation (EU) No 1017/2013 of 23 October 2013 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006. 2. However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation, may continue to be used for a maximum period of six months after the entry into force of this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Rejected health claims Application – Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data ‘Hypo-caloric snacks (KOT products)’ Contributes to reduce the adipocytes size at the abdominal level, in the context of a low-calorie diet Q-2011-00016 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) Peptides IPP and VPP help to maintain normal blood pressure Q-2011-00121 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Appl’In® polyphenolic apple extract powder ( Malus domestica ) Appl’In® contributes to decrease glycaemic response in women Q-2011-00190 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Coffee C21 Regular consumption of Coffee C21 contributes to the maintenance of DNA integrity in cells of the body Q-2011-00783 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Diacylglycerol (DAG) oil Substituting your usual vegetable oil with DAG oil helps in the management of body weight through weight loss Q-2011-00751 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Spermidine Spermidine prolongs the growing phase (anagen) of the hair cycle Q-2011-00896 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Bimuno® (Bimuno® GOS) Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce intestinal discomfort Q-2011-00401 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Sugar beet fibre Sugar beet fibre decreases intestinal transit time Q-2011-00971
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.